Peanut allergy cured a little at a time

• Autores: Andy Coghlan
• Localización: New scientist, ISSN 0262-4079, Nº. 2955, 2014, pág. 14
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • For the first time, children with a potentially lethal peanut allergy have essentially been cured using an oral immunotherapy. The trial involved 99 children with a peanut allergy aged between 7 and 16. In a hospital setting, half of the children were given a tiny dose of peanut flour in their food once a day. The same amount was then added to their meals at home for the next two weeks. At the end of the trial period, the researchers found that 41 of the 49 therapy recipients could tolerate the 800 mg dose safely and 24 of them could even handle 1400 mg. What's more, the effects of the therapy have lasted five years to date with no sign of peanut intolerance re-emerging.